Lilly stops mid-stage Alzheimer's drug study (Update)
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.
Jun 13, 2013
not rated yet |
0
not rated yet |
0
